Predicine and Merck KGaA, Darmstadt, Germany to Present Data at AACR – Advances in Liquid Biopsy Conference 2020
HAYWARD, CALIF. (PRWEB) JANUARY 07, 2020 Predicine, a molecular insights company headquartered in Hayward, California, with global footprints in China, today announced results from a collaborative biomarker study with Merck KGaA, Darmstadt, Germany, a leading science and technology company operating its biopharmaceuticals business in the U.S. and Canada as EMD Serono,[…]
Read more